KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Operating Expenses (2016 - 2025)

Boston Scientific (BSX) has disclosed Operating Expenses for 17 consecutive years, with $2.9 billion as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 17.93% to $2.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.2 billion through Dec 2025, up 15.24% year-over-year, with the annual reading at $10.2 billion for FY2025, 15.24% up from the prior year.
  • Operating Expenses hit $2.9 billion in Q4 2025 for Boston Scientific, up from $2.5 billion in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $2.9 billion in Q4 2025 to a low of $1.5 billion in Q1 2021.
  • Historically, Operating Expenses has averaged $2.0 billion across 5 years, with a median of $2.0 billion in 2021.
  • Biggest YoY gain for Operating Expenses was 45.75% in 2021; the steepest drop was 17.54% in 2021.
  • Year by year, Operating Expenses stood at $2.0 billion in 2021, then fell by 7.34% to $1.8 billion in 2022, then rose by 9.02% to $2.0 billion in 2023, then increased by 21.3% to $2.4 billion in 2024, then grew by 17.93% to $2.9 billion in 2025.
  • Business Quant data shows Operating Expenses for BSX at $2.9 billion in Q4 2025, $2.5 billion in Q3 2025, and $2.6 billion in Q2 2025.